相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
Yuhong Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy et al.
CANCER SCIENCE (2020)
Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
Yoshiro Itatani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance
Isaac Wasserman et al.
CLINICAL CANCER RESEARCH (2019)
5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy
Yeon-Joo Lee et al.
CANCERS (2019)
Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer
Forouzan Amerizadeh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade
Binhao Zhang et al.
ONCOLOGY REPORTS (2016)
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
Pu Yan et al.
CLINICAL CANCER RESEARCH (2016)
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
Gabriele Romano et al.
ONCOTARGET (2016)
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
Margaret M. Kozak et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
B. Zhang et al.
BRITISH JOURNAL OF CANCER (2014)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway
Dipon Das et al.
DNA REPAIR (2014)
5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency
K. Bracht et al.
BRITISH JOURNAL OF CANCER (2010)
In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation
R. Fanciullino et al.
BRITISH JOURNAL OF CANCER (2007)
SMAD4 levels and response to 5-fluorouracil in colorectal cancer
P Alhopuro et al.
CLINICAL CANCER RESEARCH (2005)
SMAD4 as a prognostic marker in colorectal cancer
H Alazzouzi et al.
CLINICAL CANCER RESEARCH (2005)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
JL Boulay et al.
BRITISH JOURNAL OF CANCER (2002)
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
T Watanabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease
A Maitra et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
